Industry Analysis & Industry Trends
The Pharmaceutical Product Manufacturing industry is dominated by major global pharmaceutical groups, although only a small number are engaged in the manufacture of active pharmaceutical ingredients in Australia. An increasing number of firms are limiting their local activities to the later stages of the manufacturing process, including dispensing, packaging and the fill-and-finish stage. A large number of global manufacturers also restrict their Australian activities to distribution.
As with operators in the global pharmaceutical industry, domestic players are currently contending with the effects of the patent cliff. Since 2011, some of the world's highest selling drugs have lost patent protection... purchase to read more
Industry Report - Industry Analysis Chapter
The performance of the Pharmaceutical Product Manufacturing industry has gradually deteriorated over the past five years due to a rapidly changing operating environment. The patent cliff is reshaping the global pharmaceutical industry, as some of the industry’s most profitable innovator drugs have lost patent protection over the five-year period. This has come at a time when competition from generic products is intensifying, R&D productivity is declining and costs are escalating. These variables have caused dramatic changes in the industry.
Another key variable currently shaping industry performance is the ongoing reform of the PBS... purchase to read more